Stone;Renal, Stone Ureter, Surgery
Conditions
Keywords
Holmium Laser, Laser setting, Stone fragmentation
Brief summary
The primary objective of this study is to compare the time to acceptable stone fragmentation during clinical use of the holmium laser when using energy settings 0.2J vs 0.8J. The hypothesis is that holmium laser energy settings 0.8J will require less time than lower energy settings 0.2J for fragmenting urinary stones. The clinical practice is to treat urinary stones until the stone is reduced to fragments ≤ 2 mm in size. This is determined by using the laser fiber which is 273 microns to visually estimate the size of the resultant fragments as described by Patel et al, J Endo 2014. Investigators will standardize the effect of stone size by creating a ratio of stone size to treatment time. In this study, the frequency is set at 15Hz. Thus, the study contains two arms: 0.2J&15Hz, and 0.8J&15Hz. Patients will be randomized into the two groups by the ratio of 1:1.
Detailed description
The only interventions imposed on subjects as a result of this study are (1) pre-procedural randomization to laser lithotripsy with either 0.2J or 0.8J energy setting, and (2) the use of patient information in describing results. All the other activities are part of the routine clinical practice in the department. Participation in the study will not alter the patients' preoperative, or postoperative care. During surgery, patients' stones will be treated in accordance with the routine clinical practice of fragmenting stones into small pieces (\<2 mm). All patients enrolled will undergo routine post-operative follow up including clinic appointments and imaging evaluation. Any complications will be recorded, reported, and treated appropriately. A fixed frequency will be used (15Hz). Thus, the study contains two arms: 0.2J&15Hz, and 0.8J&15Hz. Patients will be randomized into the two groups by the ratio of 1:1. A total of 1 clinic visit (i.e., the stone surgery, approximately 5-6 hours, depending on the duration of the surgery) is needed for this study. The study procedures are: 1. A study team member who is affiliated with the patient's clinical care (e.g., the surgeon) will initially approach the patients who are scheduled laser lithotripsy treatment of urinary stones. (i.e. informed that there's a research study they may be eligible for, and asked if they want to learn more about it). 2. If the patient is interested in the study, a member of the research team will approach him/her for enrollment. 3. Once the consent form is obtained, patients' medical background will be reviewed for inclusion/exclusion criteria. Patients who meet the inclusion criteria will be included in the study; patients who do not meet the inclusion criteria will be excluded. 4. Patients will be randomized to either 0.2J&15Hz or 0.8J&15Hz (randomization ratio 1:1) group. 5. Patients will undergo stone surgeries with the laser setting that they are randomized to. The patient's stone(s) will be treated in accordance with the routine clinical practice of fragmenting stone into small pieces (≤ 2mm). The faculty surgeon (i.e., Dr. Nakada) will perform all surgeries. 6. Fragmentation time as well as other information (total surgery time, complications, stone information, and number of stones treated) is collected. 7. After surgery, the patients will then continue on normal postoperative pathway. Postoperative complications will be collected.
Interventions
Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients at least 18 years of age * Patients with urinary stones who require endoscopic treatment
Exclusion criteria
* Patients \< 18 years of age * Pregnant patients * Pre-menopausal females who have not been on approved birth control for at least 1 month pre-operatively * Patients with stones known to be refractory to treatment with the holmium laser
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fragmentation Time | up to 6 hours | The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm | up to 6 hours | Size of fragments created will be assessed using the laser fiber size as a comparison. |
| Total Operative Time | up to 6 hours | — |
| Density of Urinary Stones | up to 6 hours | — |
| Number of Participants With Either Ureteral or Renal Location of Urinary Stone | up to 6 hours | Urinary stone location will be classified as renal or ureter. |
| Number of Participants Treated for Either Single or Multiple Urinary Stones | up to 6 hours | — |
| Pre-Operative Stone Size | Retrospective review of health chart at Baseline | Pre-operative stone size (on pre-operative CT) will be reported in millimeters. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Holmium:YAG Laser: 0.2J&15Hz Patients are assigned to treat stones with 0.2J&15Hz of the holmium laser.
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones) | 12 |
| Holmium:YAG Laser: 0.8J&15Hz Patients are assigned to treat stones with 0.8J&15Hz of the holmium laser.
Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones) | 15 |
| Total | 27 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lack of equipment | 1 | 1 |
| Overall Study | Physician Decision | 2 | 1 |
| Overall Study | Stone passed, surgery cancelled | 2 | 1 |
| Overall Study | Surgeries rescheduled or cancelled due to COVID | 2 | 2 |
| Overall Study | Withdrawal by Subject | 1 | 0 |
Baseline characteristics
| Characteristic | Holmium:YAG Laser: 0.2J&15Hz | Total | Holmium:YAG Laser: 0.8J&15Hz |
|---|---|---|---|
| Age, Continuous | 51 years STANDARD_DEVIATION 15.4 | 53.6 years STANDARD_DEVIATION 14.1 | 55.6 years STANDARD_DEVIATION 13.1 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants | 0 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 12 Participants | 27 Participants | 15 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 12 Participants | 27 Participants | 15 Participants |
| Region of Enrollment United States | 12 participants | 27 participants | 15 participants |
| Sex: Female, Male Female | 5 Participants | 13 Participants | 8 Participants |
| Sex: Female, Male Male | 7 Participants | 14 Participants | 7 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 12 | 0 / 15 |
| other Total, other adverse events | 0 / 12 | 0 / 15 |
| serious Total, serious adverse events | 0 / 12 | 0 / 15 |
Outcome results
Fragmentation Time
The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice)
Time frame: up to 6 hours
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Holmium:YAG Laser: 0.2J&15Hz | Fragmentation Time | 24.5 Minutes | Standard Deviation 19.2 |
| Holmium:YAG Laser: 0.8J&15Hz | Fragmentation Time | 7.9 Minutes | Standard Deviation 3.2 |
Density of Urinary Stones
Time frame: up to 6 hours
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Holmium:YAG Laser: 0.2J&15Hz | Density of Urinary Stones | 935.2 Hounsfield units | Standard Deviation 367.9 |
| Holmium:YAG Laser: 0.8J&15Hz | Density of Urinary Stones | 924.7 Hounsfield units | Standard Deviation 374.5 |
Number of Participants Treated for Either Single or Multiple Urinary Stones
Time frame: up to 6 hours
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Holmium:YAG Laser: 0.2J&15Hz | Number of Participants Treated for Either Single or Multiple Urinary Stones | Single | 8 Participants |
| Holmium:YAG Laser: 0.2J&15Hz | Number of Participants Treated for Either Single or Multiple Urinary Stones | Multiple | 4 Participants |
| Holmium:YAG Laser: 0.8J&15Hz | Number of Participants Treated for Either Single or Multiple Urinary Stones | Single | 14 Participants |
| Holmium:YAG Laser: 0.8J&15Hz | Number of Participants Treated for Either Single or Multiple Urinary Stones | Multiple | 1 Participants |
Number of Participants With Either Ureteral or Renal Location of Urinary Stone
Urinary stone location will be classified as renal or ureter.
Time frame: up to 6 hours
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Holmium:YAG Laser: 0.2J&15Hz | Number of Participants With Either Ureteral or Renal Location of Urinary Stone | Ureteral | 8 Participants |
| Holmium:YAG Laser: 0.2J&15Hz | Number of Participants With Either Ureteral or Renal Location of Urinary Stone | Renal | 4 Participants |
| Holmium:YAG Laser: 0.8J&15Hz | Number of Participants With Either Ureteral or Renal Location of Urinary Stone | Ureteral | 7 Participants |
| Holmium:YAG Laser: 0.8J&15Hz | Number of Participants With Either Ureteral or Renal Location of Urinary Stone | Renal | 8 Participants |
Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm
Size of fragments created will be assessed using the laser fiber size as a comparison.
Time frame: up to 6 hours
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Holmium:YAG Laser: 0.2J&15Hz | Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm | 1mm | 1 Participants |
| Holmium:YAG Laser: 0.2J&15Hz | Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm | 2mm | 10 Participants |
| Holmium:YAG Laser: 0.2J&15Hz | Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm | 3mm | 1 Participants |
| Holmium:YAG Laser: 0.8J&15Hz | Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm | 1mm | 5 Participants |
| Holmium:YAG Laser: 0.8J&15Hz | Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm | 2mm | 10 Participants |
| Holmium:YAG Laser: 0.8J&15Hz | Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm | 3mm | 0 Participants |
Pre-Operative Stone Size
Pre-operative stone size (on pre-operative CT) will be reported in millimeters.
Time frame: Retrospective review of health chart at Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Holmium:YAG Laser: 0.2J&15Hz | Pre-Operative Stone Size | 11.2 mm | Standard Deviation 5.2 |
| Holmium:YAG Laser: 0.8J&15Hz | Pre-Operative Stone Size | 9.2 mm | Standard Deviation 8.2 |
Total Operative Time
Time frame: up to 6 hours
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Holmium:YAG Laser: 0.2J&15Hz | Total Operative Time | 75.7 Minutes | Standard Deviation 20.6 |
| Holmium:YAG Laser: 0.8J&15Hz | Total Operative Time | 64.3 Minutes | Standard Deviation 17.2 |